Navigation Links
Imagenetix, Inc. Reports Third Quarter 2011 Results
Date:2/25/2011

ng expenses:Selling, general and administrative1,8165733,2881,956Payroll expense272325834849Consulting expense3534341,1061,009Operating expenses 2,4411,3325,2283,814Operating loss(2,024)(445)(2,687)(1,419)Other income-316Settlement income---1,250Interest expense (44)-(158)(2)Loss before income taxes(2,068)(442)(2,844)(165)Income tax benefit(866)(148)(1,108)(9)Net loss$

(1,202)$

(294)$

(1,736)$

(156)Loss per share:Basic and diluted$

(0.10)$

(0.03)$

(0.15)$

(0.01)Weighted average common shares outstanding:Basic and diluted11,81111,01111,64511,011Imagenetix, Inc. Condensed Consolidated Balance Sheets(Unaudited)(In thousands) December 31,

March 31, 2010 2010 Assets:Current assets:Cash and cash equivalents

$

171$

981Accounts receivable, net9591,049Inventories, net9881,350Prepaid expenses and other current assets282151Deferred tax asset2,034933   Total current assets4,4344,464Property and equipment, net 6789Long-term prepaid expenses918Other assets 117125   Total assets

$

4,627$

4,696Liabilities and stockholders' equity:Current liabilities:Secured note payable to bank

$

1,025$

-Convertible notes294-Accounts payable710997Accrued liabilities6783Customer deposits2225Contract payable7586   Total current liabilities2,1931,191Stockholders' equity 2,4343,505   Total liabilities and stockholders' equity

$

4,627$

4,696ContactImagenetix Investor Relations

William P. Spencer(858)385-2797

Chief Executive OfficerImagenetix, Inc.Tel: (858) 674-8455
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
2. Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  Decision Resources Group finds that the market ... $7.7 billion by 2023 in the United States ... , Italy , Spain ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s ... out by the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- Gateway Analytical announced today that ... Annual Global Pharma Manufacturing Summit in ... . The Global Pharma Manufacturing Summit offers a ... and biologic pharmaceutical manufacturing. The conference is focused ... face, such as the increasing pressure to grow ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... JUNCTION, N.J., Feb. 28, 2012  Insmed Incorporated (Nasdaq CM: INSM), ... Tuesday, March 13th, 2012, at 8:30 AM ET, to ... year-end 2011.  Insmed intends to issue its quarterly and ... on March 13th. To participate in ...
... LONDON, Feb. 28, 2012  Based on its recent ... Sullivan recognises Brainsway with the 2012 Global Frost ... deep Transcranial Magnetic Stimulation (dTMS) is the only ... treatment of depression and other neuro-psychiatric disorders without ...
Cached Medicine Technology:Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call 2Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call 3Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device 2Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device 3
(Date:8/29/2014)... these recent findings, there has been a significant rise in ... few years. Medical expert and Herpes researcher, Dr. Williams said, ... that make it hard for patients to find out if ... the exact symptoms of these ailments, others confuse it with ... of cases over the years has been a cause of ...
(Date:8/29/2014)... 2014 Hope For The Warriors® is ... Scholarships. Scholarships are awarded two times each year to ... spouses of fallen service members. Hope For The Warriors® ... of self, restoring the family unit, and restoring hope ... , The Spouse/Caregiver Scholarship Program identifies, recognizes, and rewards ...
(Date:8/29/2014)... First Choice Emergency Room opened its new ... facility is located 1501 FM 685, Pflugerville, Texas and is ... a part of First Choice Emergency Room’s second location in ... quality emergency medical care to the local community,” said Dr. ... Pflugerville – FM 685. , To celebrate the ...
(Date:8/29/2014)... North York, ON (PRWEB) August 29, 2014 ... busy professional needs to find a break in their day ... not always easy for business professionals to find a few ... this announcement by North York Dental so important. It is ... emergency care that they need. , What is happening? , ...
(Date:8/29/2014)... 2014 http://www.fdanews.com/CTMPR , FDAnews ... Magnifier Weekly. , Clinical Trial Magnifier Weekly monitors 150,000 ... and reports all the fresh changes. By sifting through ... extract just the information readers need. Subscribers are able ... links in the newsletter to focus on the ones ...
Breaking Medicine News(10 mins):Health News:It was reported that the Number on PositiveSingles.dating increased about 20% in 2014 2Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 2Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 3Health News:First Choice Emergency Room Opens New Facility in Pflugerville, Texas 2Health News:North York Dental Provides Dental Services to Busy Professionals 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 3Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 4
... Vitamin supplements can prevent hearing loss in laboratory ... step closer to the development of a pill that ... loss in humans. , The findings will be reported ... conference in Baltimore by senior author Colleen Le Prell, ...
... has experts available to discuss the current debate on ... January, Baker Institute fellows Neal Lane and Kirstin Matthews ... Obama administration. They recommend that stem cell research be ... manner and that a federal stem cell policy be ...
... 17 The National Head Start Association ... Chairperson Ron Herndon, who also is the director of ... thousands of new jobs will be created -- and ... now that President Barack Obama has signed into law ...
... GCC is the strongest independent, ... predictor of colorectal cancer recurrence -, ... 17 /PRNewswire-FirstCall/ - The Journal of the American Medical Association ... a major prospective 5-year multicenter study of over 400 enrolled ...
... Company Posts Quarterly EPS of $0.39, Total Revenues of ... by 23%, Total Revenues by 17% -- Company Generates ... Feb. 17 Gen-Probe Incorporated (Nasdaq: ... the fourth quarter and full year ended December 31, ...
... INCREASE 23 PERCENTSAN DIEGO, Feb. 17 Volcano Corporation ... development, manufacturing and sales of products for the diagnosis ... reported that revenues for the full year 2008 increased ... for the fourth quarter of 2008 increased 23 percent ...
Cached Medicine News:Health News:Vitamin supplements may protect against noise-induced hearing loss 2Health News:Vitamin supplements may protect against noise-induced hearing loss 3Health News:NHSA: President Obama, Congress Deserve High Praise for $2.1 Billion in Recovery Package for Head Start 2Health News:Major study on DiagnoCure's GCC biomarker published in Jama 2Health News:Major study on DiagnoCure's GCC biomarker published in Jama 3Health News:Major study on DiagnoCure's GCC biomarker published in Jama 4Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 2Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 3Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 4Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 5Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 6Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 7Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 8Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 9Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 10Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 11Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 12Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 13Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 14Health News:Volcano Reports Full Year Revenues Increase 31 Percent 2Health News:Volcano Reports Full Year Revenues Increase 31 Percent 3Health News:Volcano Reports Full Year Revenues Increase 31 Percent 4Health News:Volcano Reports Full Year Revenues Increase 31 Percent 5Health News:Volcano Reports Full Year Revenues Increase 31 Percent 6Health News:Volcano Reports Full Year Revenues Increase 31 Percent 7Health News:Volcano Reports Full Year Revenues Increase 31 Percent 8Health News:Volcano Reports Full Year Revenues Increase 31 Percent 9Health News:Volcano Reports Full Year Revenues Increase 31 Percent 10Health News:Volcano Reports Full Year Revenues Increase 31 Percent 11Health News:Volcano Reports Full Year Revenues Increase 31 Percent 12Health News:Volcano Reports Full Year Revenues Increase 31 Percent 13Health News:Volcano Reports Full Year Revenues Increase 31 Percent 14
... offers a truly unique surgical approach for ... (IOFB). Other magnets are available for ophthalmic ... electromagnet for use through a pars plana, ... D.O.R.C. Intraocular Electromagnet offers the most effective ...
... Earth Intraocular Magnet is especially designed for ... bodies. The precise, sleek design of this ... with electromagnetic devises. Due to its 24K ... possibility of secondary foreign body incarceration. The ...
... SureSigns C1 compact, portable monitor features ... as well as versatile spot check ... ideal for transport and low-acuity care, ... and provides the flexibility required for ...
... the M3 and M4 monitors offer wireless ... care. M Series monitors are equipped with ... set of non-invasive parameters and input for ... extensions offer Mainstream or Microstream® CO 2 ...
Medicine Products: